A community based primary prevention programme for type 2 diabetes integrating identification and lifestyle intervention for prevention: the Let's Prevent Diabetes cluster randomised controlled trial (Q38923629)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	A community based primary prevention programme for type 2 diabetes integrating identification and lifestyle intervention for prevention: the Let's Prevent Diabetes cluster randomised controlled trial	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

7 September 2017

A community based primary prevention programme for type 2 diabetes integrating identification and lifestyle intervention for prevention: the Let's Prevent Diabetes cluster randomised controlled trial (English)

1 reference

Europe PubMed Central

7 September 2017

type 2 diabetes

0 references

Jaakko Tuomilehto

5

object named as

Jaakko Tuomilehto

0 references

object named as

Laura J Gray

2

0 references

object named as

Melanie J Davies

1

0 references

object named as

Alastair Gray

4

0 references

object named as

Thomas Yates

8

0 references

7

object named as

Kamlesh Khunti

1 reference

Europe PubMed Central

7 September 2017

author name string

Jacqui Troughton

3

1 reference

Europe PubMed Central

7 September 2017

Azhar Farooqi

6

1 reference

Europe PubMed Central

7 September 2017

Let's Prevent Diabetes Team

9

1 reference

Europe PubMed Central

7 September 2017

language of work or name

0 references

publication date

28 December 2015

1 reference

Europe PubMed Central

7 September 2017

Preventive Medicine

1 reference

Europe PubMed Central

7 September 2017

84

1 reference

Europe PubMed Central

7 September 2017

48-56

1 reference

Europe PubMed Central

7 September 2017

Diet or diet plus physical activity versus usual care in patients with newly diagnosed type 2 diabetes: the Early ACTID randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.12.012

7 January 2021

Effect of a lifestyle intervention on weight change in south Asian individuals in the UK at high risk of type 2 diabetes: a family-cluster randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.12.012

7 January 2021

International physical activity questionnaire: 12-country reliability and validity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.12.012

7 January 2021

Uptake of the NHS Health Checks programme in a deprived, culturally diverse setting: cross-sectional study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.12.012

7 January 2021

Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.12.012

7 January 2021

Diabetes prevention in the real world: effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guideline recommendations: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.12.012

7 January 2021

The Fasting Hyperglycaemia Study: II. Randomized controlled trial of reinforced healthy-living advice in subjects with increased but not diabetic fasting plasma glucose

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.12.012

7 January 2021

Interpreting the results of secondary end points and subgroup analyses in clinical trials: should we lock the crazy aunt in the attic?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.12.012

7 January 2021

Delivering the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cost effectiveness analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.12.012

7 January 2021

Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.12.012

7 January 2021

Detection of impaired glucose regulation and/or type 2 diabetes mellitus, using primary care electronic data, in a multiethnic UK community setting.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.12.012

7 January 2021

Implementation of the automated Leicester Practice Risk Score in two diabetes prevention trials provides a high yield of people with abnormal glucose tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.12.012

7 January 2021

Let's prevent diabetes: study protocol for a cluster randomised controlled trial of an educational intervention in a multi-ethnic UK population with screen detected impaired glucose regulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.12.012

7 January 2021

Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.12.012

7 January 2021

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.12.012

7 January 2021

The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.12.012

7 January 2021

Progression rates from HbA1c 6.0-6.4% and other prediabetes definitions to type 2 diabetes: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.12.012

7 January 2021

Randomised controlled trial evaluating lifestyle interventions in people with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.12.012

7 January 2021

The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.12.012

7 January 2021

Dietary intervention in primary care: validity of the DINE method for diet assessment

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.12.012

7 January 2021

Excess mortality in a population with diabetes and the impact of material deprivation: longitudinal, population based study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.12.012

7 January 2021

How many steps/day are enough? Preliminary pedometer indices for public health

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.12.012

7 January 2021

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.12.012

7 January 2021

Rationale and design of the ADDITION-Leicester study, a systematic screening programme and randomised controlled trial of multi-factorial cardiovascular risk intervention in people with type 2 diabetes mellitus detected by screening

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.12.012

7 January 2021

Screening for diabetes using an oral glucose tolerance test within a western multi-ethnic population identifies modifiable cardiovascular risk: the ADDITION-Leicester study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.12.012

7 January 2021

Effectiveness of a pragmatic education program designed to promote walking activity in individuals with impaired glucose tolerance: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.12.012

7 January 2021

The hospital anxiety and depression scale

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2015.12.012

7 January 2021

Identifiers

10.1016/J.YPMED.2015.12.012

1 reference

Europe PubMed Central

7 September 2017

1 reference

Europe PubMed Central

7 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38923629&oldid=1925138437"